Incidence of Dermatitis Herpetiformis in Sweden 2005 to 2018: A Nationwide Retrospective Cohort Study
DOI:
https://doi.org/10.2340/actadv.v103.13210Keywords:
Incidence, Dermatitis Herpetiformis, Medical records, Healthcare registries, Population-based cohort studyAbstract
Dermatitis herpetiformis has been investigated in the past; however, only a limited number of studies have reported its incidence based on validated nationwide population-based registries. To address this gap, the aims of this study are to estimate the incidence of dermatitis herpetiformis in Sweden and to validate the National Patient Register (NPR) for diagnosis of dermatitis herpetiformis. A population-based open cohort study was conducted, including all patients diagnosed with dermatitis herpetiformis (International Classification of Diseases 10th revision; ICD-10 code L13.0) in Sweden from 2005 to 2018 (n = 1,724), identified from the NPR. The diagnosis of dermatitis herpetiformis in the NPR was validated using medical records, histopathological and immunopathological data, yielding a positive predictive value (PPV) of 62.5%. The mean annual incidence of dermatitis herpetiformis was 0.93/100,000 (95% confidence interval 0.79–1.08), female to male ratio 1:1, and mean age at diagnosis 60.9 years. In conclusion, this large nationwide cohort study showed a low validity for diagnosis of dermatitis herpetiformis in the NPR, and the adjusted incidence rate of dermatitis herpetiformis in Sweden was estimated to be 0.93/100,000, which is lower than that in previous Swedish studies.
Downloads
References
Reunala T, Hervonen K, Salmi T. Dermatitis herpetiformis: an update on diagnosis and management. Am J Clin Dermatol 2021; 22: 329-338.
https://doi.org/10.1007/s40257-020-00584-2 DOI: https://doi.org/10.1007/s40257-020-00584-2
Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747-757.
https://doi.org/10.1084/jem.20011299 DOI: https://doi.org/10.1084/jem.20011299
Sankari H, Hietikko M, Kurppa K, Kaukinen K, Mansikka E, Huhtala H, et al. Intestinal TG3- and TG2-specific plasma cell responses in dermatitis herpetiformis patients undergoing a gluten challenge. Nutrients 2020; 12: 467.
https://doi.org/10.3390/nu12020467 DOI: https://doi.org/10.3390/nu12020467
Taylor TB, Schmidt LA, Meyer LJ, Zone JJ. Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen. J Invest Dermatol 2015; 135: 623-625.
https://doi.org/10.1038/jid.2014.368 DOI: https://doi.org/10.1038/jid.2014.368
Collin P, Salmi TT, Hervonen K, Kaukinen K, Reunala T. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Ann Med 2017; 49: 23-31.
https://doi.org/10.1080/07853890.2016.1222450 DOI: https://doi.org/10.1080/07853890.2016.1222450
Gorog A, Antiga E, Caproni M, Cianchini G, De D, Dmochowski M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 2021; 35: 1251-1277.
https://doi.org/10.1111/jdv.17183 DOI: https://doi.org/10.1111/jdv.17183
Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol 2015; 8: 257-265.
https://doi.org/10.2147/CCID.S69127 DOI: https://doi.org/10.2147/CCID.S69127
Wolf R, Matz H, Orion E, Tuzun B, Tuzun Y. Dapsone. Dermatol Online J 2002; 8: 2.
https://doi.org/10.5070/D330M4B5KR DOI: https://doi.org/10.5070/D330M4B5KR
Huber C, Trueb RM, French LE, Hafner J. Negative direct immunofluorescence and nonspecific histology do not exclude the diagnosis of dermatitis herpetiformis Duhring. Int J Dermatol 2013; 52: 248-249.
https://doi.org/10.1111/j.1365-4632.2011.04909.x DOI: https://doi.org/10.1111/j.1365-4632.2011.04909.x
Salmi TT, Hervonen K, Kautiainen H, Collin P, Reunala T. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol 2011; 165: 354-359.
https://doi.org/10.1111/j.1365-2133.2011.10385.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10385.x
West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol 2014; 109: 757-768.
https://doi.org/10.1038/ajg.2014.55 DOI: https://doi.org/10.1038/ajg.2014.55
Smith JB, Tulloch JE, Meyer LJ, Zone JJ. The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol 1992; 128: 1608-1610. DOI: https://doi.org/10.1001/archderm.128.12.1608
https://doi.org/10.1001/archderm.1992.04530010046006 DOI: https://doi.org/10.1001/archderm.1992.04530010046006
Mobacken H, Kastrup W, Nilsson LA. Incidence and prevalence of dermatitis herpetiformis in western Sweden. Acta Derm Venereol 1984; 64: 400-404.
https://doi.org/10.2340/0001555564400404 DOI: https://doi.org/10.2340/0001555564400404
Hellier FF. The prevalence of dermatitis herpetiformis. Br J Dermatol 1972; 86: 437-438.
https://doi.org/10.1111/j.1365-2133.1972.tb05061.x DOI: https://doi.org/10.1111/j.1365-2133.1972.tb05061.x
Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol 2011; 64: 1017-1024; quiz 1025-1016.
https://doi.org/10.1016/j.jaad.2010.09.777 DOI: https://doi.org/10.1016/j.jaad.2010.09.777
Hall RP, Clark RE, Ward FE. Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. J Am Acad Dermatol 1990; 22: 436-439.
https://doi.org/10.1016/0190-9622(90)70060-U DOI: https://doi.org/10.1016/0190-9622(90)70060-U
Shibahara M, Nanko H, Shimizu M, Kanda N, Kubo M, Ikeda M, et al. Dermatitis herpetiformis in Japan: an update. Dermatology 2002; 204: 37-42.
https://doi.org/10.1159/000051808 DOI: https://doi.org/10.1159/000051808
Reunala T, Lokki J. Dermatitis herpetiformis in Finland. Acta Derm Venereol 1978; 58: 505-510.
https://doi.org/10.2340/0001555558505510 DOI: https://doi.org/10.2340/0001555558505510
Moi H. Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion. Acta Derm Venereol 1984; 64: 144-150.
https://doi.org/10.2340/0001555564144150 DOI: https://doi.org/10.2340/0001555564144150
Gawkrodger DJ, Blackwell JN, Gilmour HM, Rifkind EA, Heading RC, Barnetson RS. Dermatitis herpetiformis: diagnosis, diet and demography. Gut 1984; 25: 151-157.
https://doi.org/10.1136/gut.25.2.151 DOI: https://doi.org/10.1136/gut.25.2.151
Virta LJ, Saarinen MM, Kolho KL. Declining trend in the incidence of biopsy-verified coeliac disease in the adult population of Finland, 2005-2014. Aliment Pharmacol Ther 2017; 46: 1085-1093.
https://doi.org/10.1111/apt.14335 DOI: https://doi.org/10.1111/apt.14335
Rose C, Brocker EB, Zillikens D. Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring. J Dtsch Dermatol Ges 2010; 8: 265-270, 265-271.
https://doi.org/10.1111/j.1610-0387.2009.07292.x DOI: https://doi.org/10.1111/j.1610-0387.2009.07292.x
Ohata C, Ishii N, Hamada T, Shimomura Y, Niizeki H, Dainichi T, et al. Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years. Clin Dev Immunol 2012; 2012: 562168.
https://doi.org/10.1155/2012/562168 DOI: https://doi.org/10.1155/2012/562168
Handa S, Dabas G, De D, Mahajan R, Chatterjee D, Saika UN, et al. A retrospective study of dermatitis herpetiformis from an immunobullous disease clinic in north India. Int J Dermatol 2018; 57: 959-964.
https://doi.org/10.1111/ijd.14029 DOI: https://doi.org/10.1111/ijd.14029
Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-667.
https://doi.org/10.1007/s10654-009-9350-y DOI: https://doi.org/10.1007/s10654-009-9350-y
The Swedish Board of Health and Welfare. Quality of data and reporting procedures - National Patient register 2018. Available from: www.socialstyrelsen.se, 2018 (in Swedish).
Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
https://doi.org/10.1186/1471-2458-11-450 DOI: https://doi.org/10.1186/1471-2458-11-450
Virta LJ, Kaukinen K, Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol 2009; 44: 933-938.
https://doi.org/10.1080/00365520903030795 DOI: https://doi.org/10.1080/00365520903030795
Fry L. The falling incidence and prevalence of dermatitis herpetiformis. Br J Dermatol 2011; 165: 229.
https://doi.org/10.1111/j.1365-2133.2011.10460.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10460.x
Salmi TT, Hervonen K, Kurppa K, Collin P, Kaukinen K, Reunala T. Celiac disease evolving into dermatitis herpetiformis in patients adhering to normal or gluten-free diet. Scand J Gastroenterol 2015; 50: 387-392.
https://doi.org/10.3109/00365521.2014.974204 DOI: https://doi.org/10.3109/00365521.2014.974204
Catassi C, Verdu EF, Bai JC, Lionetti E. Coeliac disease. Lancet 2022; 399: 2413-2426.
https://doi.org/10.1016/S0140-6736(22)00794-2 DOI: https://doi.org/10.1016/S0140-6736(22)00794-2
Gardner K, Crawford R. A decreasing incidence of dermatitis herpetiformis in a gluten-free era. J Am Acad Dermatol 2017; 76: AB12.
https://doi.org/10.1016/j.jaad.2017.04.066 DOI: https://doi.org/10.1016/j.jaad.2017.04.066
Alonso-Llamazares J, Gibson LE, Rogers RS, 3rd. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Int J Dermatol 2007; 46: 910-919.
https://doi.org/10.1111/j.1365-4632.2007.03214.x DOI: https://doi.org/10.1111/j.1365-4632.2007.03214.x
Zhang F, Yang B, Lin Y, Chen S, Zhou G, Wang G, et al. Dermatitis herpetiformis in China: a report of 22 cases. J Eur Acad Dermatol Venereol 2012; 26: 903-907.
https://doi.org/10.1111/j.1468-3083.2011.04204.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04204.x
Kaplan RP, Callen JP. Overlapping cutaneous disorders related to dermatitis herpetiformis. Clin Dermatol 1991; 9: 361-368.
https://doi.org/10.1016/0738-081X(91)90027-I DOI: https://doi.org/10.1016/0738-081X(91)90027-I
Hervonen K, Salmi TT, Kurppa K, Kaukinen K, Collin P, Reunala T. Dermatitis herpetiformis in children: a long-term follow-up study. Br J Dermatol 2014; 171: 1242-1243.
https://doi.org/10.1111/bjd.13047 DOI: https://doi.org/10.1111/bjd.13047
Antiga E, Verdelli A, Calabro A, Fabbri P, Caproni M. Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience. G Ital Dermatol Venereol 2013; 148: 163-169.
Antiga E, Bonciolini V, Cazzaniga S, Alaibac M, Calabro AS, Cardinali C, et al. Female patients with dermatitis herpetiformis show a reduced diagnostic delay and have higher sensitivity rates at autoantibody testing for celiac disease. Biomed Res Int 2019; 2019: 6307035.
https://doi.org/10.1155/2019/6307035 DOI: https://doi.org/10.1155/2019/6307035
Dahlbom I, Korponay-Szabo IR, Kovacs JB, Szalai Z, Maki M, Hansson T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr 2010; 50: 140-146.
https://doi.org/10.1097/MPG.0b013e3181a81384 DOI: https://doi.org/10.1097/MPG.0b013e3181a81384
Reunala T, Salmi TT, Hervonen K. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet. Acta Derm Venereol 2015; 95: 917-922.
https://doi.org/10.2340/00015555-2162 DOI: https://doi.org/10.2340/00015555-2162
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Zeyad Albadri, Doua Al Bayati, Henrike Häbel, Sandra Jerkovic Gulin, Carina Grönhagen, Oliver Seifert
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
